T-cells

December 22, 2020December 22, 2020

DPX-Survivac Responses Now Up to 16 Months in Advanced Ovarian Cancer Trial

News

IMV‘s immunotherapy DPX-Survivac plus low-dose chemotherapy continues to show sustained benefits in people with heavily treated advanced ovarian cancer, with some benefits lasting up to 16 months, updated findings from a ... Read more

September 17, 2020September 17, 2020

Checkpoint Inhibitor CTX-2026 Shows Promising Efficacy in Preclinical Study

News

Compass Therapeutics‘ CTX-2026, an antibody targeting the protein BTN3A1, could be therapeutic in ovarian cancer by helping the immune system destroy cancer cells, preclinical data show. The study, “BTN3A1 governs ... Read more

June 16, 2020June 16, 2020

DPX-Survivac Shows Durable Responses in Advanced Ovarian Cancers, Trial Data Show

News

A combination of IMV‘s immunotherapy DPX-Survivac plus intermittent low-dose cyclophosphamide leads to sustained responses in women with heavily-treated advanced ovarian cancer, with some responses lasting more than 10 months, updated ... Read more

May 20, 2019

Ampligen Showing Promise for Recurrent Ovarian Cancer in Phase 1/2 Trial, Phase 2 Study Now Recruiting

News

Hemispherx Biopharma‘s experimental therapy Ampligen (rintatolimod) can change the tumor microenvironment to increase the amount of infiltrating T-cells, an approach that is showing promise in a Phase 1/2 clinical trial ... Read more

April 2, 2018

Personalized Immunotherapy May Be Effective Ovarian Cancer Treatment, Study Finds

News

A new method that identifies and expands T-cells with high tumor-killing activity is a promising approach against ovarian cancer, a study shows. Findings could be used to develop a personalized, cell-based ... Read more

September 19, 2016September 19, 2016

New Alternative Found for Boosting Ovarian Cancer Immune Responses

News

Researchers at The Wistar Institute in Philadelphia have identified an experimental drug that shows great promise in halting ovarian cancer progression. The treatment, which is currently in clinical trials for a number ... Read more

August 3, 2016August 3, 2016

Specific Ovarian Cancer-tailored Immunotherapy Appears Effective in Mouse Models

News

Researchers at the Wistar Institute identified a new protein that is expressed on the surface of different types of ovarian cancer cells. This protein can therefore be targeted to treat ... Read more